PFIZER REPORTS THIRD-QUARTER 2017 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- BioNTech ends colorectal cancer mRNA therapy trial early
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Pinterest CFO resigns, interim replacement named
Pfizer (PFE) Tops Q3 EPS by 2c, Lifts FY EPS Guidance
October 31, 2017 6:46 AM EDT(Updated - October 31, 2017 6:49 AM EDT)
Pfizer (NYSE: PFE) reported Q3 EPS of $0.67, $0.02 better than the analyst estimate of $0.65. Revenue for the quarter came in at $13.17 billion versus the consensus estimate of $13.17 billion.
EXECUTIVE COMMENTARY
Ian Read, Chairman and Chief Executive Officer, stated, We reported solid third-quarter 2017 financial results and raised the midpoint of the range for our 2017 Adjusted diluted EPS(2) guidance.... More
